A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Colorectal Cancer · Esophagus Cancer · Gastric Cancer · Pancreas Cancer · Non-small Cell Lung Cancer · Breast Cancer · Bile Duct Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Contact: Study coordinator (Weijia Fang, MD) · weijiafang@zju.edu.cn · 13758211655
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Contact: Study coordinator (Ying Y, MD) · yuanying1999@tom.com · 13858193601

Study leads

Ying Yuan, M.D
Principal Investigator
Second Affiliated Hospital, School of Medicine, Zhejiang University
Weijia Fang, M.D
Principal Investigator
Zhejiang University

View source on ClinicalTrials.gov